Simone Schmitt | Senior Director Antibody Development
Memo Therapeutics AG
Simone Schmitt has over 13 years of experience in antibody development and discovered more than 5 best-in-class antibodies. Pior to building the microfluidic high-troughput B cell cloning and screening platform at Memo Therapeutics she worked at Delenex Therapeutics. Simone holds a PhD in Biochemistry from LMU Munich.
Appearances:
Festival of Biologics Day 2 @ 15:20
Superior antiviral antibodies from cognate recombinant antibody repertoires of human donors
last published: 12/Apr/24 08:55 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events